Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Filings indexed 392 across all filing types
Latest filing 2022-11-09 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
Regulatory Filings
2022-11-09 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a detailed credit rating report issued by CARE Ratings Limited for Chemfab Alkalis Limited. It includes comprehensive information about the company's business operations, financial performance, key rating drivers, risks, liquidity, and future prospects. The report discusses the company's financial metrics, capital expenditure plans, and market conditions in detail. It is not a brief announcement or a certification letter but a full analytical credit rating report. Such reports are typically classified under Regulatory Filings (RNS) or Audit Report / Information (AR). However, since this is a credit rating report and not an audit report or internal stress test, and it does not contain full financial statements but detailed credit rating analysis, the most appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is not a short announcement or a report publication notice. Therefore, the filing type code is RNS with high confidence.
2022-11-08 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of the SEBI (Listing Regulations and Disclosure Requirements) Regulations, 2015, which pertains to reporting loss of share certificates. The content is a notification or intimation about a specific event related to share certificates, not a financial report, earnings release, or management discussion. The document length is 6490 characters, but the content is essentially a regulatory notification about share certificate loss. This fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2022-11-04 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification from Chemfab Alkalis Limited to stock exchanges about the allotment of equity shares under an employee stock option scheme (CAESOS 2020). It details the number of shares allotted, the increase in paid-up share capital, and compliance with SEBI regulations. The document is an announcement of a share allotment event and capital change, not a financial report or detailed analysis. It is short (4014 characters) and serves as an official disclosure of a capital change due to share allotment under an employee stock option plan. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2022-11-04 English
Outcome of Board Meeting
Regulatory Filings
2022-11-03 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the issuance of a duplicate share certificate. It references Regulation 39(3) of the SEBI Listing Regulations, which pertains to share certificate loss and reissuance. The content includes details of the shareholder, share certificate numbers, and dates related to the issuance of the duplicate certificate. There is no financial data, earnings information, management discussion, or report publication mentioned. The document is a regulatory announcement about share certificate issuance, specifically a duplicate certificate, which fits the category of a Regulatory Filing (RNS) rather than a financial report or capital change announcement. It is not a share issue or capital change (SHA) because it deals with duplicate certificates, not new shares or capital restructuring.
2022-10-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.